Table 3. Predictors of AKI in derivation cohorts (n = 455).
OR | 95% CI | p-value | ||
---|---|---|---|---|
Lower | Upper | |||
Obese vs non-obese | 1.28 | 0.72 | 2.26 | 0.399 |
eGFR < 90 (ml/min/1.73 mq) | 2.78 | 1.78 | 4.35 | <0.001 |
SOFA cv ≥2 | 2.23 | 1.48 | 3.37 | <0.001 |
Lactate ≥2 (mmol/L) | 1.81 | 1.19 | 2.74 | 0.005 |
(TIMP-2)•(IGFBP7) ≥ 0.3 ((ng/ml)2/1000) | 1.65 | 1.08 | 2.52 | 0.019 |
eGFR = estimated glomerular filtration rate SOFAcv = cardiovascular sequential organ failure assessment; TIMP-2, tissue inhibitor of metalloproteinases 2.; IGFBP7, insulin-like growth factor-binding protein 7